Series A valuations, M&A in 2024, and M.A.N.G with Jason Shuman and Raja Doddala | E1883

Episode Summary

Executive Summary: The panel examines a venture market recovering unevenly from the downturn: Series A and late-stage valuations are rising, but investors warn that AI-driven and strategic deals may distort benchmarks. They favor sober traction-based underwriting, disciplined follow-ons, and selective liquidity. Strategic corporate investments, secondary funds, and returning IPO/M&A activity offer opportunities but also create valuation, conflict, and execution risks.

Main Topics: Startup valuations and underwriting discipline: Panelists debate rising Series A prices, noting that AI moonshots and large funds seeking ownership can skew market data. They advocate evaluating recent revenue, product-market fit, and execution rather than relying on ambitious forecasts; traditional B2B SaaS valuations were described as more restrained. AI investment and corporate strategic capital: Microsoft, Amazon, NVIDIA, and Google have become more prominent investors, often for strategic positioning rather than conventional returns. Participants warn that investments tied to cloud credits, chip purchases, or commercial relationships can inflate valuations, create conflicts, and complicate exits. Where venture investors see potential alpha: The guests discuss pre-seed, seed, and Series A as potential entry points. Seed offers access to early winners but requires broad sourcing and evaluation; Series A may offer better risk-adjusted opportunities when investors insist on demonstrated traction and disciplined pricing. Secondaries and managing fund liquidity: Secondary funds are raising large pools, but Raja questions strategies based mainly on price arbitrage and doubts there are enough quality distressed assets. The guests support selective sales of part of strong positions to return capital while retaining upside, rather than selling under pressure. Portfolio construction and follow-on decisions: JCal describes restricting follow-ons to likely or definitive winners and avoiding routine bridge rounds; Primary emphasizes conviction and close operating involvement. Historical results show concentration can drive returns, but unexpected fund-returners may also emerge from less obvious portfolio companies. IPO and M&A recovery: Guests see pent-up IPO inventory and private-equity dry powder as possible catalysts for liquidity. A healthier exit market depends on companies becoming profitable and public offerings delivering sustainable returns, not just first-day trading gains.

Key Arguments: Headline valuation data can be misleading: AI companies and large funds pursuing target ownership stakes may lift reported Series A figures, even while many managers apply stricter traction and pricing standards. Investors should test recent performance against forward plans. Reviewing the last several months of revenue and asking how the company will meet near-term milestones is more reliable than underwriting distant projections alone. Strategic corporate investors can offer substantial capital and partnership value, but their motivations differ from those of financial investors. Commercial dependencies and conflicts may constrain a startup's choices and make later financing or an exit harder. Secondary transactions are not automatically attractive merely because they appear discounted. Selective sales can generate DPI and manage risk, but managers should avoid surrendering promising assets based only on an assumed pricing arbitrage. Follow-on capital should be allocated competitively. JCal says his fund prioritizes companies with strong external leads and rapid growth, while Primary also considers founder learning speed, execution, and information gained through close operating support. Concentration can magnify returns, but a rigid focus on the obvious top performers can miss eventual winners. One cited fund analysis found most value came from a minority of investments, while other portfolio examples demonstrate that timing and market adoption can change outcomes. More IPOs and M&A could restore liquidity and confidence, but profitability, reasonable pricing, and investors' ability to earn returns are crucial to reopening the market sustainably.

Data Points: Median Series A valuation: $38.8 million in Q3 2023 to $45.5 million in Q4 2023, approximately +17% - Carta figures cited in the discussion; the panel cautions that AI deals may distort the aggregate. Peak median Series A valuation: $48.2 million - Q1 2022, cited as the peak of the zero-interest-rate-policy era for comparison. AI infrastructure seed valuations: $39 million median; $56 million mean - Figures cited by Jason Schuman; he said these deals were seeing about a 2.1x step-up at Series A. Forward revenue multiples: 8–12x for more predictable B2B SaaS; 25–35x for less predictable or purportedly weak product-market fit companies - Market ranges described by Jason Schuman; he contrasted the latter with multiples of 50–60x in boom times. Series E and later median valuation: $251 million in Q1 2023 to $708 million in Q4 2023, a reported 182% increase - Raised as a concern given the scarcity of multi-billion-dollar exits. Median IPO exit size: $110 million - Raja cited PitchBook/NVCA data while questioning whether later-stage valuations align with achievable exits. Selected large technology-company share of VC market: 1% in 2022 to 8% in 2023 - The transcript groups Microsoft, Amazon, NVIDIA, and Google investments under the label “MANG”; the panel says strategic investment motives can distort venture-market comparisons. Lexington secondary fund: $22.7 billion raised against an initial $15 billion target; 40% reportedly deployed across 50 deals - Capital raised by Lexington Capital Partners 10, as reported in the episode. Seed-stage premium for LPs: Historically 5–8% - Raja described a potential premium associated with seed and pre-seed investing, alongside the operational burden of assessing many managers. Venture fund value concentration: 91% of value came from 14% of investments; 23.9% of capital went into those investments - Jason Schuman referenced analysis of a fund that returned more than 10x to illustrate the case for concentrating capital. Primary investment pace and diligence: 3–4 new checks per partner annually; about 5 investor meetings and 4 customer calls for a deal - Jason Schuman described the firm's concentrated process and customer-call diligence. Potential DocuSign buyout price: Up to $95 per share - A Bank of America analyst estimate cited amid reports of private-equity interest.

Pivotal Quotes: "I think this is going to be a bad vintage for those investors." — Jason Calacanis: He warned that investing at high post-money valuations in companies without traction could produce poor venture returns. "If you're an existing shareholder, you're happy. If you're a new shareholder buying at the new inflated price, you might want to take a second look at that." — Jason Calacanis: He summarized the difference between benefiting from an existing strategic investment and buying into a potentially inflated valuation. "Our agreement with our LPs is we do not do bridge rounds, we do price rounds." — Jason Calacanis: He explained his fund's stated follow-on policy and its emphasis on reserving capital for evidence-backed winners.

Implications: Founders should prioritize real traction, profitability, and clean financing terms; investors should scrutinize AI-led valuations and corporate deal structures. Selective secondaries and renewed IPO/M&A activity may restore liquidity, but durable recovery depends on credible pricing and exits.